ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,67%
Bitcoin
66 993,57
2,69%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zura Bio Ltd (ZURA)

  7. Zura Bio Ltd (ZURA) Actualités

ZURA

Zura Bio (ZURA)

Zura Bio Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ZURA
DateHeureSourceTitreSymboleSociété
09/05/202412h00Business WireZura Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
18/04/202415h22Business WireZura Bio Announces Oversubscribed $112.5 Million Private PlacementNASDAQ:ZURAZura Bio Ltd
08/04/202412h00Business WireZura Bio Announces Robert Lisicki as CEO and DirectorNASDAQ:ZURAZura Bio Ltd
28/03/202411h00Business WireZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerNASDAQ:ZURAZura Bio Ltd
04/03/202412h00Business WireZura Bio Announces Participation at March ConferencesNASDAQ:ZURAZura Bio Ltd
23/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
14/02/202415h02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZURAZura Bio Ltd
02/02/202412h00Business WireZura Bio Announces Participation at February Investor ConferencesNASDAQ:ZURAZura Bio Ltd
26/01/202417h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
08/01/202412h00Business WireZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMONASDAQ:ZURAZura Bio Ltd
03/01/202412h00Business WireZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitNASDAQ:ZURAZura Bio Ltd
04/12/202312h00Business WireZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNASDAQ:ZURAZura Bio Ltd
17/11/202323h53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
14/11/202312h00Business WireZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNASDAQ:ZURAZura Bio Ltd
13/11/202312h30Business WireZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
15/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZURAZura Bio Ltd
14/09/202323h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZURAZura Bio Ltd
12/09/202311h00Business WireZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteNASDAQ:ZURAZura Bio Ltd
25/08/202303h54Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
14/08/202313h00Business WireZura Bio Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
23/06/202314h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZURAZura Bio Ltd
23/06/202312h30Business WireZura Bio to Join the Russell 2000® and Russell 3000® IndexesNASDAQ:ZURAZura Bio Ltd
22/06/202323h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZURAZura Bio Ltd
22/06/202323h20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ZURAZura Bio Ltd
22/06/202323h17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZURAZura Bio Ltd
16/06/202319h31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ZURAZura Bio Ltd
14/06/202312h03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ZURAZura Bio Ltd
06/06/202310h00Business WireZura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual AntagonistNASDAQ:ZURAZura Bio Ltd
19/05/202322h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZURAZura Bio Ltd
12/05/202323h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZURAZura Bio Ltd
 Showing the most relevant articles for your search:NASDAQ:ZURA

Dernières Valeurs Consultées

USOTC
CURN
Currency Exchange (PK)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés